(Q39785094)

14 September 2017

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses (English)

1 reference

14 September 2017

1 reference

Chien SC

1

1 reference

14 September 2017

Rogge MC

2

1 reference

14 September 2017

Gisclon LG

3

1 reference

14 September 2017

Curtin C

4

1 reference

14 September 2017

Wong F

5

1 reference

14 September 2017

Natarajan J

6

1 reference

14 September 2017

Williams RR

7

1 reference

14 September 2017

Fowler CL

8

1 reference

14 September 2017

Cheung WK

9

1 reference

14 September 2017

Chow AT

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

41

1 reference

14 September 2017

2256-2260

1 reference

14 September 2017

10

1 reference

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

Quinolone antibacterials. An update of their pharmacology and therapeutic use.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

In vitro activity of DR-3355, an optically active ofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

Fluoroquinolone antimicrobial agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

Intravenous-to-oral antibiotic switch therapy. A cost-effective approach

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164102

Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9333057

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Noncompartmental determination of the steady-state volume of distribution during multiple dosing

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9333057

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.41.10.2256

0 references

1 reference

14 September 2017

1 reference